Search BioPortfolio:
BioPortfolio
Web
Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
BioNews - BioPortfolio's News Portal
Biotechnology Regulatory Headlines
Sign-up to BioPortfolio's
Biotechnology Regulatory FDA news alerts
.
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Press Trust of India:
similar ...
From the Editor: The Right Stuff
Pharmaceutical Manufacturing Magazine:
similar ...
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalizat
DiGiTAL50:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hosp
Antara Interactive:
similar ...
NeurogesX to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
KOTA Territory News:
similar ...
Biophage Pharma announces sale of Immunotox Labs Division to Validapro BioSciences Inc
Yahoo! Canada:
similar ...
NeurogesX Reports First Quarter 2008 Results
KOTA Territory News:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Canadian Business Magazine:
similar ...
COMMUNIQUE: PR Newswire: BELG Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in
Belga Direct Press Releases:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Bolsamania:
similar ...
Landmark ATHENA Study Findings With Multaq (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization
Pharma Live:
similar ...
Landmark ATHENA Study Findings With Multaq(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation
Financial Post:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
TradingMarkets:
similar ...
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalizat
Macro World Investor:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Canada NewsWire:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Yahoo! Canada:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Market Wire:
similar ...
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalizat
PR Newswire:
similar ...
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows
PR Newswire via MSN Money:
similar ...
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalizat
Stockwatch:
similar ...
